The American Society of Hematology (ASH) and the International Society on Thrombosis and Hemostasis (ISTH) released new and ...

Background: Canada has historically been among the world leaders in hypertension care, but hypertension treatment and control rates have regressed in recent years. This guideline is intended to ...

This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR ...

Medtronic (NYSE: MDT) announced today that it received CE mark for several expanded indications for its Prevail balloon ...

The Company expects to submit an Investigational Device Exemption (IDE) and commence U.S. clinical trials in 2025 to support ...

FORT MILL, S.C., May 14, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced ...

Imperative Care has completed subject enrolment in the pivotal investigational device exemption (IDE) trial, SYMPHONY-PE, assessing the Symphony thrombectomy system's efficacy and safety in treating ...

Regulatory and Safety Considerations The UK government and regulatory bodies such as the Medicines and Healthcare Products Regulatory Agency (MHRA) are emphasizing patient safety by enforcing strict ...

Fasting before cardiac catheterization procedures with any type of anesthesia has been common practice, and was reaffirmed in the 2023 Practice Guidelines for Preoperative Fasting from the ...

The new guidelines include 14 good practice statements ... removal of catheters, and catheter selection WHO will continue to work with countries to develop and implement best practices to reduce ...

Mr Aylward said the new guidelines included 14 good practice statements and 23 recommendations on key areas for health workers, including education and training, as well as techniques of asepsis ...

Regarding indications for catheter ablation, one major change in this document is upgraded advice for the use of this technology as a first-line treatment for patients with symptomatic paroxysmal AF.